Volume 12, Number 6—June 2006
Dispatch
Class 1 Integrons in Resistant Escherichia coli and Klebsiella spp., US Hospitals
Aarati N. Rao*1, Miriam Barlow*2, Leigh Ann Clark†, John R. Boring*, Fred C. Tenover†, and John E. McGowan*
Table 2
Association of nonsusceptibility to various antimicrobial agents and presence of integrons in Escherichia coli and Klebsiella spp. (Klebsiella pneumoniae and K. oxytoca)*
| Antimicrobial drug | Estimate | OR (95% CI) | p value† |
|---|---|---|---|
| E. coli | |||
| Gentamicin‡ | 1.16 | 3.19 (1.40–7.30) | 0.006 |
| Ciprofloxacin | 0.31 | 1.37 (0.46–4.03) | 0.573 |
| Ceftazidime | –0.81 | 0.45 (0.14–1.45) | 0.180 |
| Cefepime | –1.77 | 0.17 (0.04–0.82) | 0.027 |
| Piperacillin-tazobactam | –0.38 | 0.68 (0.28–1.66) | 0.407 |
| Aztreonam | 1.19 | 3.29 (0.90–12.0) | 0.071 |
| Chloramphenicol | 0.29 | 1.34 (0.60–2.99) | 0.476 |
| Minocycline | –0.11 | 0.89 (0.39–2.06) | 0.791 |
| Trimethoprim-sulfamethoxazole‡ | 2.56 | 12.9 (5.73–29.0) | <0.001 |
| Source§ | 1.10 | 3.02 (1.23–7.45) | 0.02 |
| Intercept | –2.43 | <0.0001 | |
| Klebsiella spp. | |||
| Gentamicin | 1.44 | 4.23 (1.48–12.03) | 0.007 |
| Ciprofloxacin | 0.34 | 1.40 (0.43–4.56) | 0.578 |
| Ceftazidime | 0.92 | 2.51 (0.49–12.80) | 0.270 |
| Cefepime | 0.05 | 1.05 (0.27–4.14) | 0.942 |
| Piperacillin-tazobactam | 0.02 | 1.02 (0.26–4.07) | 0.979 |
| Aztreonam | –1.64 | 0.19 (0.04–0.99) | 0.048 |
| Chloramphenicol | –0.57 | 0.57 (0.13–2.44) | 0.447 |
| Minocycline | 0.13 | 1.14 (0.35–3.73) | 0.835 |
| Trimethoprim-sulfamethoxazole | 1.52 | 4.61 (1.39–15.29) | 0.012 |
| Source§ | 0.56 | 1.75 (0.64–4.78) | 0.275 |
| Intercept | –0.28 | 0.591 | |
*Multivariate logistic regression with variables included for 1 drug of each major class that was tested. Hosmer and Lemeshow goodness-of-fit test statistic: E. coli total χ2 = 10.852, df = 8, p = 0.21; Klebsiella spp. total χ2 = 4.538, df = 8, and p = 0.81. OR, odds ratio; CI, confidence interval.
†By χ2 approximation.
‡Significant interaction between these 2 variables (p<0.001).
§Nonurine source vs. urine source (reference).
1Current affiliation: Midwestern University, Glendale, Arizona, USA
2Current affiliation: University of California at Merced, Merced, California, USA
Page created: January 04, 2012
Page updated: January 04, 2012
Page reviewed: January 04, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.